14th December 2017
We are delighted to announce the award of two new Project Grants.
Totaling almost £500,000, the awards support blood cancer researchers whose projects show the most potential for advancing the fundamental understanding of blood cancers, or improvement in diagnosis or treatment for patients
Leading researchers at UCL Great Ormond Street Institute of Child Health and at the University of Oxford will each receive one of these innovative new Project Grants created and funded by Leuka.
Dr Jasper de Boer and Dr Owen Williams at UCL Great Ormond Street Institute of Child Health have been awarded funding for a pre-clinical study that could create a vital new treatment for acute leukaemia in infants and adult leukaemia that has been caused by previous cancer treatment. If successful the study, supported by Leuka’s grant, could lead to life-changing clinical trials.
Professor Jackie Boultwood and Dr Andrea Pellagatti at the University of Oxford will be delving deeper into study of Chronic Myelomonocytic Leukaemia, which currently has a poor prognosis. Their project aims to create a new cell-based model of CMML. Once they have achieved this they will be able to better understand the molecular mechanisms of CMML and identify new drugs and therapies for this blood disorder.
Leuka Chief Executive Olive Boles said, “We are incredibly excited by the research these projects will be undertaking. With 26 people diagnosed with leukaemia each day, it is imperative that we support research that can be translated into clinical trials and treatments. Both of these projects have the potential to do just that to help improve the lives of leukaemia and blood cancer patients around the UK.”